Management of pharmacovigilance during the COVID‐19 pandemic crisis by the safety department of an academic sponsor: Lessons learnt and challenges from the EU DisCoVeRy clinical trial

The current COVID‐19 pandemic was an exceptional health situation, including for drug use. As there was no known effective drug for COVID‐19 at the beginning of the pandemic, different drug candidates were proposed. In this article, we present the challenges for an academic Safety Department to mana...

Descripción completa

Detalles Bibliográficos
Autores principales: Mercier, Noémie, Belhadi, Drifa, DeChanet, Aline, Delmas, Christelle, Saillard, Juliette, Dumousseaux, Marina, Le Mestre, Soizic, Fougerou‐Leurent, Claire, Ferrane, Assia, Burdet, Charles, Espérou, Hélène, Ader, Florence, Hites, Maya, Peiffer‐Smadja, Nathan, Poissy, Julien, Andrejak, Claire, Paiva, José Artur, Tacconelli, Evelina, Staub, Thérèse, Greil, Richard, Costagliola, Dominique, Mentre, France, Yazdanpanah, Yazdan, Diallo, Alpha
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley and Sons Inc. 2023
Materias:
Reviews
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10238756/
https://www.ncbi.nlm.nih.gov/pubmed/37269068
http://dx.doi.org/10.1002/prp2.1072

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10238756/
https://www.ncbi.nlm.nih.gov/pubmed/37269068
http://dx.doi.org/10.1002/prp2.1072

Ejemplares similares